Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
57 Cards in this Set
- Front
- Back
Sympathetic Post-ganglionic
|
•Release Norepinephrine
•Stimulate alpha and beta receptors •Metabolized by MAO & COMT ( enzymes responsible for breaking down) |
|
Parasympathetic Post-ganglionic
|
•Release Acetylcholine
•Stimulate muscarinic receptors •Metabolized by cholinesterase |
|
Pharmacology is the study of drugs and can be divided into two sub-sciences?
|
•Pharmacodynamics: what drugs do to the body
•Pharmacokinetics: what the body does to drugs and how fast it does it (e.g. absorption, distribution, metabolism, excretion) |
|
Pharmacotherapeutics: Treatment of disease by drugs
|
•Palliative (most drugs)
•Curative (some drugs) |
|
Drug absorption (passage of drug from site of administration into bloodstream) and
Drug distribution (passage of drug from bloodstream to site of action) are determined by? |
a)Drug molecular size
b)Drug solubility c)Conditions at site of tissues to be penetrated by drug |
|
Alpha 1 antagonist stimulates what of the iris?
|
Alpha 1 antagonist stimulation of radial muscle of iris causes mydriasis
|
|
Alpha 1 antagonist stimulates arterioles causing?
|
Alpha 1 antagonist stimulation of arterioles causes vasoconstriction.
|
|
Beta 1 & 2 antagonist stimulate?
|
Beta 1 & 2 antagonist stimulation of heart causes + inotropic and + chronotropic response.
( increase heart rate, increase BP) |
|
Beta 2 antagonist stimulates?
|
Beta 2 stimulation of bronchus causes bronchodilation.
|
|
Epinephrine - category?
|
Ans- sympathetic
|
|
Epinephrine MOAction?
|
Alpha and beta antagonist
|
|
Epinephrine district characteristics ?
|
Ineffective orally
Sort half life |
|
Epinephrine actions or uses ?
|
Positive inotrophic & chronotrophic
Bronchodilator Like local anesthesia |
|
Phenylephrine category?
|
ANS sympathomimetic
|
|
Phenylephrine MOA ?
|
Alpha 1 antagonist
|
|
Phenylephrine distinct characteristics ?
|
Effective orally
Limiters CNS access |
|
Phenylephrine actions and uses ?
|
Nasal congestion
CNS stimulation |
|
Isoproterenol category?
|
ANS sympathy mimetic
|
|
Isoproterenol MOA?
|
Beta 1&2 antagonist
|
|
Isoproterenol distinct characteristics?
|
Metabolized by COMT
Shirt duration of action |
|
Pseudoephedrine category?
|
ANS Symapathomimetric
|
|
Pseudoephedrine MOA?
|
Indirect acting
|
|
Pseudoephedrine distinct characteristics?
|
Crosses blood brain barrier
Effective orally |
|
Pseudoephedrine actions & uses ?
|
Nasal congestion
CNS stimulation |
|
Albuterol category?
|
ANS Symapathomimetic
|
|
Albuterol MOA?
|
Beta 2 antagonist
|
|
Albuterol distinct characteristics ?
|
Several hour duration of action
|
|
Albuterol actions and uses?
|
Bronchodialator
Limited cardiac effect Selective vasodilation |
|
Clonodine category?
|
ANS Sympathomimetric
Anti hypertensive |
|
Clonodine MOA?
|
Alpha 2 antagonist
|
|
Clonodine distinctive characteristics?
|
Effective orally
Crosses blood brain barrier CNS Alpha preference Long half life |
|
Clonodine actions & uses ?
|
Centrally acting anti hypertensive
Dry mouth Sedation Sexual dysfunction |
|
Acetylcholine category ?
|
•Category: ANS- Parasympathomimetic
|
|
Acetylcholine MOA?
|
•MOA: Muscarinic and nicotinic agonist
|
|
Acetylcholine Distinguishing characteristics
|
–Rapidly hydrolyzed by esterases
–Acts on both muscarinic and nicotinic receptors –Quaternary ammonium group invokes polarity |
|
Acetylcholine characteristics
|
–Short half life (seconds)
–Diffuse activity (parasympathomimetic, sympathomimetic and skeletal muscle) –Limited distribution |
|
Acetylcholine actions and uses ?
|
•Predictable uses: Possible local ophthalmic use, but other products better.
|
|
Phenelzine category?
|
ANS Sympathomimetic
|
|
Phenelzine MOA ?
|
MAO inhibitor
|
|
Phenelzine characteristics?
|
Crosse blood brain barrier
Readily absorbed |
|
Phenelzine actions and uses?
|
Increased catecholamine levels
Used as antidepressant Interacts with symathomimetrics |
|
Reserpine category ?
|
ANS sympatholytic
|
|
Reserpine MOA ?
|
Norepinephrine depletor
|
|
Reserpine characteristics ?
|
Anti quated
|
|
Reserpine actions and uses ?
|
Decreases blood pressure
Effects exceeds presence Initial sympathommimmeffect |
|
Prazocin category ?
|
ANS sympatholytic and anti hypertensive
|
|
Prazocin MOA?
|
Alpha 1antagonnist
|
|
Prazocin characteristics ?
|
Highly protein bound
Effective orally Limited reflex tachycardia |
|
Prazocin actions and uses?
|
Diminish peripheral resistance
May cause syncope Mitosis |
|
Propranolol category ?
|
ANS sympatholytic
Anti hypertensive Anti arrhythmic Antianginal |
|
Propranolol MOA?
|
Beta 1&2 antagonist
|
|
Propranolol characteristics ?
|
1 st pass metabolism
Highly lipid soluble |
|
Propranolol actions and uses ?
|
Antiarrytymic
Antianginal Risk to asthmatics Risk to diabetes |
|
Metoprolol category ?
|
ANS sympatholytic
Anti hypertensive |
|
Metoprolol MOA?
|
Beta 1 antagonist
|
|
Metoprolol characteristics ?
|
1 st pass metabolism
Highly lipid soluble |
|
Metoprolol actions and uses ?
|
Negative inotropic and chronotropic
Limited asthmatic & diabetic risk |